Dr. Holly Pederson discusses the role of hereditary cancer genetic testing in assessing your personal risk for breast, ovarian, and other cancers. This session will help you understand who should consider genetic testing, what results may reveal, how testing impacts screening and prevention plans, and how to talk to your provider about whether it’s right for you.

The session will begin with a 30-minute overview from Dr. Pederson, followed by a 30-minute live Q&A moderated by Dr. Lisa Larkin. Dr. Pederson will address real-time audience questions as well as those submitted in advance, offering practical insights on navigating genetic testing and making informed decisions about your health.

Holly Pederson, MD, MSCP, is a board-certified internal medicine physician and nationally recognized expert in breast cancer risk assessment and hereditary cancer genetics. She is the Director of Medical Breast Services at the Cleveland Clinic and has extensive experience guiding women through genetic testing, risk-reducing strategies, and individualized screening plans. Dr. Pederson is deeply committed to empowering women with knowledge that leads to earlier detection and better outcomes.

Dr. Lisa Larkin, MD, FACP, MSCP, IF, will moderate the discussion, lending her expertise in women’s preventive health and cancer risk assessment. As the founder of HERmedicine and Ms.Medicine, Dr. Larkin is dedicated to advancing personalized, evidence-based care for women throughout every stage of life.